Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2020 01:03 ET | Source: ORPHAZYME A/S

Preliminary results for 2019 and financial outlook for 2020

THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION...
January 31, 2020 02:26 ET | Source: ORPHAZYME A/S

Capital increase of 20,650 shares (equivalent to approximately 0.10% of the existing shares) in Orphazyme A/S as a result of an issue of bonus shares to KLSDC and UCLB

Orphazyme A/SCompany announcement No. 06/2020 ...
January 25, 2020 09:05 ET | Source: ORPHAZYME A/S

Resolutions passed at the Extraordinary General Meeting in Orphazyme A/S

Orphazyme A/SCompany announcement No. 05/2020Company Registration No. 32266355 Copenhagen, Denmark, January 25,...
January 07, 2020 09:16 ET | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No. 04/2020 ...
January 06, 2020 08:00 ET | Source: ORPHAZYME A/S

Orphazyme announces US Early Access Program for Niemann-Pick disease Type C

Orphazyme A/SCompany announcement No....
January 03, 2020 05:29 ET | Source: ORPHAZYME A/S

Notice to convene Extraordinary General Meeting in Orphazyme A/S - CORRECTION

Orphazyme A/SCompany announcement No....
January 03, 2020 03:01 ET | Source: ORPHAZYME A/S

Notice to convene Extraordinary General Meeting in Orphazyme A/S

Orphazyme A/SCompany announcement No....
January 03, 2020 01:00 ET | Source: ORPHAZYME A/S

Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Niemann-Pick disease Type C

Orphazyme A/SCompany announcement No....
December 19, 2019 10:46 ET | Source: ORPHAZYME A/S

Major shareholder announcement

Orphazyme A/SCompany announcement No....
December 18, 2019 01:00 ET | Source: ORPHAZYME A/S

Orphazyme’s arimoclomol receives US Fast Track designation in sporadic Inclusion Body Myositis

Orphazyme A/SCompany announcement No....